Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.22B
Enterprise Value4.91B
P/E Ratio56.24
PEG Ratio-2.38
Price/Sales Ratio6.29
Price/Book Ratio1.13
Enterprise/Revenue5.41
Enterprise/EBITDA33.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.11
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue649.51M
Revenue/Share3.8
Gross Profit104.69M
EBITDA103.66M
Net Income91.41M
Diluted EPS0.46

Balance Sheet

Total Cash1.4B
Total Cash/Share6.98
Total Debt16.32M
Total Debt/Equity0
Current Ratio7.23
Book Value Per Share20.96

Price History

52-Week Change-15.34
52-Week High30.48
52-Week Low21.81
Moving Average 50 Days24.36
Moving Average 200 Days25.35

Statistics

Average Volume3.23M
Shares Outstanding202.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield4.23
Payout Ratio1.08
Last Split Factor3:2
Last Split DateJune 17, 2022
AD